Indicators
Indicators
Value
Direction
MACD(12,26,9)
-0.131
Neutral
RSI(14)
42.188
Neutral
STOCH(KDJ)(9,3,3)
16.433
Sell
ATR(14)
0.475
Low Volatility
CCI(14)
-178.897
Sell
Williams %R
99.408
Oversold
TRIX(12,20)
0.079
Sell
StochRSI(14)
0.000
Sell
Avantor Inc
AVTR12.310USD
-0.705-5.42%
Close 09/12, 16:00（ET）Quotes delayed by 15 min
8.39BMarket Cap
12.21P/E TTM
TradingKey Stock Score
Overall Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Peer Comparison
TradingKey Stock Score
Currency: USD Updated：2025-09-12Key Insights
The company's fundamentals are relatively healthy. Its valuation is considered fairly valued,and institutional recognition is very high. Over the past 30 days, multiple analysts have rated the company as a Hold. Despite an average stock market performance, the company shows strong fundamentals and technicals. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Score
Support & Resistance
No Data
Score Analysis
Current score
Previous score
Analyst Rating
Based on
23
analysts
Hold
Current Rating
14.007
Target Price
+13.78%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Company Highlights
StrengthsRisks
Avantor, Inc. is a life science tools company and global provider of mission-critical products and services to the life sciences and advanced technology industries. The Company’s segments include Laboratory Solutions and Bioscience Production. Within its segments, it sells materials and consumables, equipment and instrumentation and services and specialty procurement to customers in the biopharma and healthcare, education and government and advanced technologies and applied materials industries. Materials and consumables include ultra-high purity chemicals and reagents, lab products and supplies, highly specialized formulated silicone materials, customized excipients, and others. Equipment and instrumentation include filtration systems, virus inactivation systems, incubators, analytical instruments, and others. Services and specialty procurement include onsite lab and production, equipment, procurement and sourcing and biopharmaceutical material scale-up and development services.
Undervalued
The company’s latest PE is 12.18, at a low 3-year percentile range.
Institutional Selling
The latest institutional holdings are 685.31M shares, decreasing 10.07% quarter-over-quarter.
Held by Van Duyn Dodge & E. Morris Cox
Star Investor Van Duyn Dodge & E. Morris Cox holds 117.43M shares of this stock.
Higher Market Activity
The company has more investor interest, with a 20-day turnover ratio of 0.92.
Financial Health
Currency: USD Updated：2025-09-12The company's current financial score is 7.34, which is higher than the Healthcare Equipment & Supplies industry's average of 7.15. Its financial status is stable, and its operating efficiency is average. Its latest quarterly revenue reached 1.58B, representing a year-over-year decrease of 5.86%, while its net profit experienced a year-over-year decrease of 6.79%.
Score
Financials
6.66
Key Metrics
Cash and cash equivalents
Total assets
Total liabilities
Free cash flow
No Data
Quality of Earnings
7.74
Operational Efficiency
7.56
Growth Potential
7.58
Shareholder Returns
7.15
Company Valuation
Currency: USD Updated：2025-09-12The company’s current valuation score is 4.80, which is higher than the Healthcare Equipment & Supplies industry's average of 2.15. Its current P/E ratio is 13.05, which is 252.70% below the recent high of 46.03 and -65.91% above the recent low of 21.65.
Score
Valuation Dimensions
P/E
P/B
P/S
P/CF
Industry Ranking 35/207
No Data
Earnings Forecast
Currency: USD Updated：2025-09-12The company’s current earnings forecast score is 6.96, which is lower than the Healthcare Equipment & Supplies industry's average of 7.66. The average price target for Avantor Inc is 13.50, with a high of 19.00 and a low of 12.00.
Score
Support & Resistance
No Data
Analyst Rating
Based on
23
analysts
Hold
Current Rating
14.007
Target Price
+13.78%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
45
Total
3
Median
6
Average
Company name
Ratings
Analysts
Avantor Inc
AVTR
23
Apple Inc
AAPL
49
Ge Vernova Inc
GEV
34
Tapestry Inc
TPR
21
Verisk Analytics Inc
VRSK
19
Genuine Parts Co
GPC
13
1
2
3
...
9
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
No Data
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Price Momentum
Currency: USD Updated：2025-09-12The company’s current price momentum score is 9.02, which is higher than the Healthcare Equipment & Supplies industry's average of 7.47. Sideways: Currently, the stock price is trading between the resistance level at 14.51 and the support level at 11.35, making it suitable for range-bound swing trading.
Score
Support & Resistance
No Data
Indicators
The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.
This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.
Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.
Moving Average
Indicators
Value
Direction
MA5
12.778
Sell
MA10
12.997
Sell
MA20
13.013
Sell
MA50
12.986
Sell
MA100
13.110
Sell
MA200
16.100
Sell
Institutional Confidence
Currency: USD Updated：2025-09-12The company’s current institutional recognition score is 10.00, which is higher than the Healthcare Equipment & Supplies industry's average of 7.19. The latest institutional shareholding proportion is 100.52%, representing a quarter-over-quarter decrease of 3.67%. The largest institutional shareholder is Van Duyn Dodge & E. Morris Cox, holding a total of 117.43M shares, representing 17.23% of shares outstanding, with 18.25% increase in holdings.
Score
Institutional Shareholding
No Data
Shareholder Activity
Name
Shares Held
Chg %
T. Rowe Price Investment Management, Inc.
BlackRock Institutional Trust Company, N.A.
State Street Global Advisors (US)
Manulife Investment Management (North America) Limited
New Mountain Capital, LLC
Clarkston Capital Partners, LLC
Geode Capital Management, L.L.C.
1
2
Risk Assessment
Currency: USD Updated：2025-09-12The company's beta value is 0.98. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets.
Score
Beta vs S&P 500 index
0.99
VaR
+3.48%
240-Day Maximum Drawdown
+57.10%
240-Day Volatility
+46.09%
Return
Best Daily Return
60 days
+5.65%
120 days
+11.27%
5 years
+12.18%
Worst Daily Return
60 days
-15.48%
120 days
-16.58%
5 years
-16.58%
Sharpe Ratio
60 days
-0.43
120 days
-0.75
5 years
-0.27
Risk Assessment
Maximum Drawdown
240 days
+57.10%
3 years
+59.64%
5 years
+74.60%
Return-to-Drawdown Ratio
240 days
-0.92
3 years
-0.22
5 years
-0.15
Skewness
240 days
-1.20
3 years
-0.60
5 years
-0.53
Volatility
Realised Volatility
240 days
+46.09%
5 years
+38.04%
Standardised True Range
240 days
+4.97%
5 years
+6.35%
Downside Risk-Adjusted Return
120 days
-86.17%
240 days
-86.17%
Maximum Daily Upside Volatility
60 days
+41.83%
Maximum Daily Downside Volatility
60 days
+46.12%
Liquidity
Average Turnover Rate
60 days
+1.92%
120 days
+1.84%
5 years
--
Turnover Deviation
20 days
+92.48%
60 days
+60.32%
120 days
+53.54%
Peer Comparison
Currency: USD Updated：2025-09-12Avantor Inc
AVTR
6.56 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Insulet Corp
PODD
7.87 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Cencora Inc
COR
7.61 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Stevanato Group SpA
STVN
7.61 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
STERIS plc
STE
7.38 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Abbott Laboratories
ABT
7.33 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
View more
The Stock Score data is powered by TradingKey and updated daily. Rating data is sourced from LESG. Please use the data with caution for reference purposes only.
